Acuity CFO Holcom sells 4,974 AYI shares

Acuity Inc. senior vice president and chief financial officer Karen J. Holcom reported an automatic stock transaction under a pre-arranged Rule 10b5-1 trading plan adopted on October 29, 2025.

Rhea-AI Filing Summary

Acuity Inc. senior vice president and chief financial officer Karen J. Holcom reported an automatic stock transaction under a pre-arranged Rule 10b5-1 trading plan adopted on October 29, 2025.

On January 28, 2026, she exercised 897 non-qualified stock options at $239.76 per share into common stock, then sold 4,974 common shares at $309.23 per share. Following these transactions, she directly beneficially owned 21,523 shares of common stock and indirectly owned 302.3631 shares through a 401(k) plan.

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider HOLCOM KAREN J

Role SVP & Chief Financial Officer

Sold 4,974 shs ($1.54M)

Approx. gross sale proceeds $1.54M

Approx. exercise cost $215K

Type	Security	Shares	Price	Value
Exercise	Non-Qualified Stock Option	897	$0.00	$0.00
Exercise	Common Stock	897	$239.76	$215K
Sale	Common Stock	4,974	$309.23	$1.54M
holding	Common Stock	--	--	--

Holdings After Transaction: Non-Qualified Stock Option — 0 contracts (Direct); Common Stock — 21,523 shares (Direct); Common Stock — 302.3631 shares (Indirect, By 401(k) Plan)

Footnotes (2)

1. F1. The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2025.
2. F2. This option vested in equal annual installments over a three-year period and was fully vested on October 24, 2019.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did AYI CFO Karen Holcom report on this Form 4?

AYI CFO Karen J. Holcom reported exercising 897 non-qualified stock options and selling 4,974 common shares. The option exercise price was $239.76 per share, and the sale price was $309.23 per share, all on January 28, 2026, under a pre-set trading plan.

How many Acuity (AYI) shares does CFO Karen Holcom own after this transaction?

After the reported trades, CFO Karen Holcom directly beneficially owned 21,523 Acuity common shares. She also indirectly held 302.3631 additional shares through a 401(k) plan, as disclosed in the Form 4, reflecting her ongoing equity stake in the company.

Was the AYI CFO’s January 28, 2026 stock sale under a Rule 10b5-1 plan?

Yes. The filing states the transactions occurred automatically under a Rule 10b5-1 trading plan adopted by Karen Holcom on October 29, 2025. Such plans pre-schedule trades, helping separate them from day-to-day decisions about the company’s prospects.

What stock option did AYI’s CFO exercise in this Form 4 filing?

Karen Holcom exercised a non-qualified stock option for 897 Acuity common shares at a $239.76 exercise price. The option vested in equal annual installments over three years and was fully vested on October 24, 2019, before being exercised on January 28, 2026.

What were the prices for AYI CFO Karen Holcom’s January 28, 2026 trades?

The non-qualified stock option was exercised at $239.76 per share into 897 common shares. She then sold 4,974 common shares at $309.23 per share. These prices are specifically disclosed in the Form 4 transaction tables for that date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/30/2026 - 04:02 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HOLCOM KAREN J

(Last) (First) (Middle)

C/O ACUITY INC.

1170 PEACHTREE STREET, NE, SUITE 1200

(Street)

ATLANTA GA 30309

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
ACUITY INC. (DE) [ AYI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/28/2026		M(1)		897	A	$239.76	26,497	D
Common Stock	01/28/2026		S(1)		4,974	D	$309.23	21,523	D
Common Stock								302.3631	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option	$239.76	01/28/2026		M			897	(2)	10/24/2026	Common Stock	897	$0	0	D

Explanation of Responses:

1. The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 29, 2025.

2. This option vested in equal annual installments over a three-year period and was fully vested on October 24, 2019.

Remarks:

	/s/ Chanda Kirchner, Attorney-in-Fact for Karen J. Holcom	01/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.